Another study reported that the Hb response rate and Hb concentration increased in a dose-dependent manner in patients with CKD undergoing hemodialysis and in those who did not require hemodialysis during a 4-week treatment period with roxadustat (35). The gene discussed is GSTM1; the disease is chronic kidney disease.